Lipid-Lowering Nutraceuticals for an Integrative Approach to Dyslipidemia

Dyslipidemia is a treatable risk factor for atherosclerotic cardiovascular disease that can be addressed through lifestyle changes and/or lipid-lowering therapies. Adherence to statins can be a clinical challenge in some patients due to statin-associated muscle symptoms and other side effects. There...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheung, Brian, Sikand, Geeta, Dineen, Elizabeth H., Malik, Shaista, Barseghian El-Farra, Ailin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219430/
https://www.ncbi.nlm.nih.gov/pubmed/37240523
http://dx.doi.org/10.3390/jcm12103414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219430/
https://www.ncbi.nlm.nih.gov/pubmed/37240523
http://dx.doi.org/10.3390/jcm12103414

Ejemplares similares